CBD FAQ – The Biggest Set of Questions and Answers 2026

CBD (cannabidiol) is currently the most searched cannabinoid on the Polish internet. According to the 2024 Fakty Konopne report, the market for CBD products in Poland reached a value of approximately 130 million euros, and the forecast for 2028 predicts 200 million euros (Hemp Facts). With popularity comes an increase in questions and doubts, for which it is difficult to find reliable answers in one place.

This article is the largest set of questions and answers about CBD on the Polish internet. We have gathered over 35 frequently asked questions from readers, store customers, and search engines, and then answered them based on the positions of WHO, FDA, EMA, EFSA, studies from PubMed, Frontiers in Pharmacology, and Permanente Journal. Each answer includes a reference to the source.

We have organized the questions into eight thematic sections: biological and chemical basics of CBD, safety and side effects, dosing and method of use, types of products, Polish law, applications and indications, drug interactions, and practical shopping tips. You can read them sequentially or jump to the section that interests you. Each section is self-contained and provides the necessary background information.

KEY INFORMATION
– The WHO assessed CBD as safe and non-addictive at typical doses in 2018 (WHO ECDD, 2018).
– CBD is legal in Poland if the THC content in the product does not exceed 0.3% (Dz.U. 2005/179/1485).
– A safe starting dose is 10-20 mg daily, increased every 3-7 days (Project CBD, 2023).
– CBD does not cause euphoria or intoxication, unlike THC.
– 66.7% of patients reported improved sleep after a month of using CBD (Permanente Journal, 2019).
– Every good product should have a current COA from an independent laboratory.

CBD – the basics: what is it and how does it work?

CBD (cannabidiol) is a phytocannabinoid derived from hemp Cannabis sativa L. It constitutes 10-20% of the dry flower mass in fiber varieties (Nature, 2021). The WHO Expert Committee on Drug Dependence confirmed in its 2018 report its non-psychoactive profile and lack of addictive potential at wellness doses (WHO, 2018).

What is CBD and how is it different from THC?

CBD is cannabidiol, one of over a hundred cannabinoids present in cannabis. THC (tetrahydrocannabinol) is the second most well-known. Both have the molecular formula C21H30O2, but differ in molecular geometry. THC strongly activates the CB1 receptor in the brain, which induces a psychoactive effect. CBD has a million times weaker affinity for CB1 and acts indirectly on the endocannabinoid system (Frontiers in Pharmacology, 2020).

In practice, this means that CBD does not cause a "high", does not alter consciousness, and does not impair cognitive abilities. Therefore, it is used in wellness products sold legally over the counter. THC in Poland is a controlled substance, and its permissible content in cannabis products is up to 0.3%.

How does CBD affect the endocannabinoid system?

The endocannabinoid system (ECS) is a network of CB1 and CB2 receptors, endogenous ligands (anandamide, 2-AG), and enzymes that break down these compounds. CBD does not bind strongly to CB1 or CB2 but modulates their activity allosterically. It inhibits the breakdown of anandamide by the FAAH enzyme, which increases the pool of natural cannabinoids in the body (PMC, Frontiers in Pharmacology, 2020).

CBD also activates the serotonin receptor 5-HT1A, known for its role in mood and anxiety regulation. Additionally, it affects vanilloid receptors TRPV1, GPR55, and peroxisome proliferator-activated receptor gamma (PPAR-gamma). This broad profile explains why the effects of CBD are multifaceted and not limited to a single mechanism.

What plant does CBD come from?

CBD is obtained from hemp Cannabis sativa L., referred to in Polish law as fiber hemp. These are the same hemp plants used to make ropes, insulation, animal feed, and food seeds. Recreational marijuana comes from other varieties of Cannabis sativa, cultivated for high THC content. Fiber hemp has THC below 0.3% (ISAP, Dz.U. 2005/179/1485).

Is CBD natural or synthetic?

Most CBD on the market is a natural extract from hemp biomass, obtained through CO2 or ethanol extraction methods. There is also synthetic CBD, produced in laboratories, but in Poland it constitutes a marginal segment mainly used in research. The cannabidiol molecule is identical regardless of its origin, but natural extract additionally contains terpenes and smaller cannabinoids (CBG, CBN, CBC), which creates an entourage effect.

What is the "entourage effect" in the context of CBD?

The entourage effect is the phenomenon of mutual enhancement of the effects of cannabinoids and terpenes, described by Russo and Mechoulam in the British Journal of Pharmacology in 2011 (PMC, British Journal of Pharmacology, 2011). In practice, this means that broad-spectrum extract works more effectively than pure CBD isolate given at the same dose. Terpenes such as myrcene, linalool, beta-caryophyllene, and pinene modulate the pharmacological profile of the product.

What is the endocannabinoid system (ECS)?

The ECS is a regulatory system present in all vertebrates, described in the 1990s. It regulates sleep, appetite, mood, pain, immune response, thermoregulation, and energy homeostasis. CB1 receptors are mainly found in the central nervous system, while CB2 receptors are in peripheral immune tissues. The body's endogenous ligands, anandamide and 2-AG, are synthesized on demand and quickly broken down by FAAH and MAGL enzymes.

Does CBD work the same for everyone?

No. The reaction to CBD is very individual and depends on the density of CB1/CB2 receptors, the activity of cytochrome P450 enzymes, body weight, diet, and the current state of the endocannabinoid system. In a 2019 Permanente Journal study, the percentage of patients reporting improved sleep after the first month was 66.7%, but after two months, the effect fluctuated (Permanente Journal, 2019). Therefore, patience and observation of one's own reaction are necessary.

The WHO Expert Committee on Drug Dependence stated in its critical report from 2018 that "CBD does not exhibit potential for abuse or dependence in humans and has a favorable safety profile even at very high doses up to 1500 mg per day" (WHO, 2018). This key position has become the basis for the deregulation of CBD in many countries.

Safety and side effects of CBD

The safety profile of CBD is one of the best documented among plant-derived compounds. A retrospective clinical study from the Permanente Journal in 2019 involving 72 patients showed that only a small percentage reported mild side effects: drowsiness (12%), dry mouth (11%), mild diarrhea (8%) (Permanente Journal, 2019). None required hospitalization.

Is CBD safe for health?

Yes, at typical wellness doses of 10-50 mg daily. WHO assessed CBD as well tolerated in humans at doses up to 1500 mg daily (WHO, 2018). The FDA in the monograph for Epidiolex states that therapeutic doses reaching 25 mg/kg body weight daily in children with drug-resistant epilepsy are well tolerated by most patients (FDA, 2018).

The safety of CBD is also confirmed in long-term studies, extending over several years of observation in pediatric populations with Dravet and Lennox-Gastaut syndromes. No severe, irreversible side effects have been reported. This is a significantly better result than for most psychotropic drugs.

Does CBD cause addiction?

No. The WHO Expert Committee on Drug Dependence explicitly stated that CBD has no addictive potential or abuse potential (WHO, 2018). This is one of the main reasons why CBD is not controlled on the list of narcotic substances in Poland or in most EU countries. The lack of action on the CB1 receptor means the absence of a reward mechanism responsible for addiction.

Does CBD have side effects?

The most commonly reported side effects are drowsiness (especially at doses above 50 mg), dry mouth, mild diarrhea, lowered blood pressure, and decreased appetite (Permanente Journal, 2019). At very high therapeutic doses of Epidiolex (25 mg/kg), the FDA noted transient elevations in liver enzymes ALT and AST in some patients, so periodic liver monitoring is required for pharmacological CBD.

For typical wellness doses of 10-30 mg daily, the risk of hepatotoxicity is negligible, provided CBD is not combined with other liver-loading medications. Dry mouth results from the inhibition of saliva secretion by CB receptor subtypes. It resolves spontaneously after a few days or after reducing the dose.

Does CBD affect the liver?

Very high doses of CBD (above 300 mg daily in adults) can raise liver enzyme levels. In the registration studies of Epidiolex, the FDA noted transient increases in ALT in 14% of patients who combined CBD with valproate (FDA, 2018). At typical wellness doses (10-50 mg), the risk is minimal. If you have a chronic liver condition, consult a hepatologist before using CBD.

Can CBD be taken during pregnancy or breastfeeding?

No. The FDA in a 2023 statement explicitly advises against the use of CBD and other cannabinoids during pregnancy and breastfeeding (FDA, 2023). The reason: lack of safety data for the developing fetus and newborn. Cannabinoids cross the placenta and accumulate in breast milk. The EMA holds a similar position regarding hemp products.

Is CBD safe for seniors?

Yes, but considering the polypharmacy typical of older age. Most seniors take medications for hypertension, diabetes, anticoagulants, or statins. CBD inhibits the CYP3A4 and CYP2C9 enzymes that metabolize these drug groups. Consultation with the attending physician before starting supplementation is essential. In the context of sleep and muscle tension, which many seniors complain about, CBD shows a beneficial profile at low doses of 10-20 mg.

A retrospective study from the Permanente Journal in 2019 included 72 adults with anxiety and insomnia. After the first month of CBD supplementation at doses of 25-75 mg daily, 79.2% of patients reported a decrease in anxiety, and 66.7% reported improved sleep quality. Only 8 individuals reported mild side effects (Permanente Journal, 2019).

When seeking natural support for sleep and tension, it is worth remembering that CBD works well with other adaptogens. If you are interested in combining it with adaptogenic plants, check out adaptogenic extracts and ashwagandha extract available in the u Bucha store.

Dosing CBD and method of use

The most common question in the Polish internet is: how much CBD to take. Project CBD in its 2023 guidelines recommends the "start low, go slow" protocol, starting from 10-20 mg daily and increasing every 3-7 days until the desired effect is achieved (Project CBD, 2023). WHO assessed CBD as well tolerated in humans at doses up to 1500 mg daily (WHO, 2018).

What is a safe starting dose of CBD?

10-20 mg of CBD daily, divided into 1-2 doses. This corresponds to 4-8 drops of 5% oil (one drop contains about 2.5 mg) or 2-4 drops of 10% oil (one drop about 5 mg). After 3-7 days, assess the effect on sleep, tension, and well-being. If it is sufficient, stay at that dose. If not, increase by 5-10 mg. Project CBD emphasizes that the CBD dose-effect curve has an inverted U-shape: too high doses yield weaker effects (Project CBD, 2023).

How to count CBD drops?

Standard rule: 1 ml of oil is about 20 drops. In 5% oil (500 mg CBD in 10 ml), one drop contains about 2.5 mg of cannabidiol. In 10% oil (1000 mg in 10 ml), about 5 mg, in 15% about 7.5 mg, in 20% about 10 mg. These are approximate values; accuracy depends on the dropper. Modern oils have precise droppers with ml markings, making dosing easier.

When to take CBD – in the morning or evening?

It depends on the goal. Low doses (5-15 mg) can be taken in the morning without causing drowsiness, for reducing tension and supporting intermediate concentration. Higher doses (25-50 mg) work better in the evening due to their mild sedative effect. Many people split the dose in half, taking it in the morning and evening for a steady serum level. Frontiers in Pharmacology in a 2020 review indicates that a steady concentration of CBD in serum is achieved after 1-2 weeks of regular use (Frontiers in Pharmacology, 2020).

How long do you need to take CBD to feel the effect?

A single sublingual dose takes effect in 15-45 minutes, capsules in 60-120 minutes, and edible forms (gummies) similarly to capsules. The full effect of ECS modulation appears after 2-4 weeks of regular use, as cannabinoids influence enzyme expression and receptor density. This is not a "pill that works immediately", but a gradual modulation of the body's regulatory system.

Can you overdose on CBD?

Clinically understood overdose with life-threatening potential is not possible. WHO emphasizes that CBD does not affect the respiratory center in the brainstem, unlike opioids (WHO, 2018). Very high doses (above 500 mg at once) can, however, cause strong drowsiness, dizziness, diarrhea, and transient increases in liver enzymes. However, no deaths from CBD overdose have been recorded in the medical literature.

Do you need to take CBD every day?

For the full effect of ECS modulation – yes. Occasional single doses work in the context of "here and now", but long-term support for sleep, reduction of tension, or mood improvement requires cumulative effects. Project CBD recommends a minimum of 4 weeks of regular use before assessing the full effect (Project CBD, 2023). However, there is no risk of dependence or withdrawal, so you can stop at any time.

From the Bucha editorial office: From our observations, customers most often discontinue CBD after 7-10 days, discouraged by the lack of immediate effect. Meanwhile, the full effect requires 3-4 weeks of regular dosing. Patience and consistency are key. We recommend keeping a daily record of well-being on a scale of 1-10 and comparing weekly averages.

Project CBD in its 2023 dosing guidelines recommends the "start low, go slow" protocol: start with 10-20 mg daily, increase by 5-10 mg every 3-7 days, until reaching the individual "optimal zone", usually in the range of 25-75 mg. Higher doses do not always provide a stronger effect due to the inverted dose-effect curve (Project CBD, 2023).

Types of CBD products – oil, capsules, cosmetics

CBD oils in concentrations of 2.5-30%, capsules, gummies, dried flowers, cosmetics, balms, and e-liquids are available on the Polish market. According to a Project CBD survey from 2023, 78% of global CBD consumers choose sublingual oils due to ease of dosing and bioavailability (Project CBD, 2023). Each form has its advantages and limitations.

What is the difference between CBD oil, capsules, and gummies?

Sublingual oil drops have the fastest absorption (15-45 minutes) and a bioavailability of 13-19% (PMC, Frontiers in Pharmacology, 2020). Capsules work slower (60-120 minutes) with a bioavailability of 6-15%, due to first-pass metabolism in the liver. Gummies behave like capsules but have slower release. Oil also provides the greatest dosing flexibility.

What are broad spectrum, full spectrum, and isolate?

Broad spectrum is an extract with the entire profile of cannabinoids and terpenes but without THC (zero or below the detection limit). Full spectrum contains the full profile, including trace THC up to 0.3%. Isolate is pure 99% cannabidiol, without other compounds. Project CBD indicates that the entourage effect in broad and full spectrum provides stronger action than isolate at the same dose of CBD (Project CBD, 2023).

For those avoiding THC due to professional work (drivers, athletes, pilots), broad spectrum is optimal. Full-spectrum products are chosen by those seeking maximum entourage effect without concerns about detection. Isolates are mainly used in clinical research and by individuals allergic to other cannabis components.

What are CBD dried flowers and how are they used?

CBD dried flowers are dried flower clusters of fiber hemp with a naturally high content of CBD or CBDA. They are sold as collectible products or for smoking incense. In Poland, they cannot be advertised as food products. The quality of the dried flower is measured by the content of CBD/CBDA, terpene profile, and absence of contaminants. An accredited COA is standard.

If you are interested in a specific dried flower, check out Kosmos hemp flower with 6.5% CBDA or Mars flower with 9% CBD. Both products have a full COA and were selected for the u Bucha offer for their terpene quality.

What are CBD cosmetics?

CBD cosmetics are creams, balms, ointments, massage oils, and facial serums with added cannabidiol extract. They work locally and do not significantly enter the bloodstream. They are most commonly recommended for: acne, atopic dermatitis, psoriasis, dry skin, and muscle and joint pain. Frontiers in Pharmacology in a 2020 review describes the anti-inflammatory and antibacterial effects of CBD on the skin (Frontiers in Pharmacology, 2020).

What is CBG and how does it differ from CBD?

CBG (cannabigerol) is another non-psychoactive cannabinoid, a biosynthetic precursor to CBD, THC, and CBC. Referred to as the "mother of cannabinoids". In a mature plant, it is usually found at less than 1% CBG compared to 10-20% CBD (Nature, 2021). CBG activates CB1 and alpha-2 adrenergic receptors more strongly, providing a more "focusing" profile than CBD, which is "calming". It works synergistically with CBD in broad and full spectrum preparations.

Bucha data Q1 2026: In our category of oils, bestsellers are always broad spectrum products (about 78% of orders), not isolates (12%) or full spectrum with THC (10%). Polish customers prefer "broad, but without THC", meaning maximum entourage effect without the risk of detection. This is a clear signal of market expectations.

According to Project CBD guidelines from 2023, broad spectrum oils, containing the full profile of cannabinoids and terpenes without THC, are most often chosen by European consumers due to the combination of entourage effect with the absence of THC detection risk in roadside and workplace tests (Project CBD, 2023).

CBD and the law in Poland 2026

The legal status of CBD in Poland is primarily regulated by the Act on Counteracting Drug Addiction Dz.U. 2005 No. 179 item 1485 with subsequent amendments and EU regulations regarding Novel Food (ISAP, 2024). Cannabidiol is not listed as a controlled substance. It is legal provided it comes from fiber hemp and contains a maximum of 0.3% THC.

Is CBD legal in Poland in 2026?

Yes. CBD is fully legal in Poland if it comes from hemp Cannabis sativa L. and the THC content in the final product does not exceed 0.3%. It can be legally purchased, possessed, used, and sold online and in physical stores. The 0.3% limit is harmonized with most EU countries, although in some countries (e.g., Switzerland) it is 1%.

Is CBD a dietary supplement in Poland?

No, due to its Novel Food status. The European Commission classified CBD extracts as novel food in 2019, requiring individual EFSA authorization before being introduced into food and supplements (EFSA, 2022). EFSA in 2022 suspended further evaluation pending the completion of toxicological data. Until approval, CBD products in Poland are sold as cosmetics, wellness products, or collectibles.

What is Novel Food and how does it affect CBD?

Novel Food is an EU category for food products that have not been widely consumed before 1997. They require individual EFSA authorization confirming safety. CBD extracts were added to the list in 2019. The authorization procedure is complex and costly, which is why no CBD extract has full registration as Novel Food to date. Hence the category of "cosmetic" or "wellness product" in the store.

Can CBD be taken on a trip?

Within the European Union, usually yes, if the product has a COA certificate and THC content below 0.3%. It is advisable to carry a printed COA in case of inspection. Outside the EU, the situation is more complicated: Singapore, UAE, Saudi Arabia, Japan have restrictive regulations or total bans. Check local regulations before traveling. In the USA, federally, CBD from hemp with THC below 0.3% is legal, but states differ in specifics.

Does CBD require a prescription?

No. Wellness CBD products are available over the counter. The exception is Epidiolex (purified pharmaceutical CBD approved by the FDA and EMA), which in Poland requires a specialist prescription and is used for severe drug-resistant epilepsy (EMA, 2019). For the typical consumer choosing 5-10% CBD oil, a prescription is not required, nor is it available, as it is a product outside the healthcare system.

The Polish Internet Legal Acts System in the current version of the Act on Counteracting Drug Addiction does not list CBD as a controlled substance. According to Dz.U. 2005 No. 179 item 1485 with subsequent amendments, fiber hemp with THC content up to 0.3% in the dry mass of the flower is allowed for cultivation and processing (ISAP, 2024).

Applications and indications of CBD

The most frequently cited areas of CBD applications are: anxiety, sleep, chronic pain, drug-resistant epilepsy, recovery after training, skin conditions. The Frontiers in Pharmacology review from 2020 lists over 50 disease entities in which CBD research is being conducted (Frontiers in Pharmacology, 2020). Only Epidiolex has full pharmaceutical registration for epilepsy indications.

Does CBD help with anxiety?

Yes, in clinical studies. JAMA Penn State published an analysis in 2017 showing that CBD reduces symptoms of social anxiety in adults at doses of 300-600 mg taken once before a stressful situation (CAVITY, 2017). The mechanism is activation of the 5-HT1A serotonin receptor and indirect support of GABA tone. The Frontiers in Pharmacology review from 2020 confirms anxiolytic effects in most studies.

Does CBD help you sleep?

Yes, in many observational studies. In a retrospective study from the Permanente Journal in 2019, 66.7% of patients reported improved sleep after the first month of CBD supplementation at doses of 25-75 mg daily (Permanente Journal, 2019). CBD is not a classic sleeping pill; it works indirectly by reducing tension, regulating cortisol rhythm, and supporting the endocannabinoid system.

Does CBD help with pain?

Yes, particularly with inflammatory and neuropathic pain. The Frontiers in Pharmacology review from 2020 describes the effectiveness of CBD in chronic pain through its action on CB2 receptors, TRPV1, and anti-inflammatory pathways (Frontiers in Pharmacology, 2020). Its effectiveness for acute pain (e.g., post-traumatic) is lower. Oral oils plus topicals (creams, balms) are most commonly recommended for specific pain locations.

Does CBD work for epilepsy?

Yes, in severe drug-resistant epilepsy. Epidiolex (purified CBD) was approved by the FDA in 2018 for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, and in 2020 for seizures associated with tuberous sclerosis (FDA, 2018). The EMA registered it in the EU as Epidyolex in 2019. It is the only cannabinoid drug with full registration on the European market. Therapeutic doses reach 10-25 mg/kg body weight.

Does CBD support recovery after training?

Yes. Frontiers in Physiology in a 2020 review describes the potential of CBD in reducing muscle inflammation, delayed onset muscle soreness (DOMS), and supporting recovery. The mechanism is anti-inflammatory action on cytokines (IL-6, TNF-alpha) and support for sleep, which is a key factor in recovery. Typical doses for athletes are 25-50 mg daily, plus topicals for specific muscle groups after training.

Does CBD help with acne?

Yes, in in vitro and pilot in vivo studies. The Journal of Clinical Investigation in 2014 described that CBD inhibits sebum production by sebocytes and acts anti-inflammatory and antibacterial against P. acnes (JCI, 2014). Typical applications are creams, serums, or spot ointments with 0.5-3% CBD, applied 1-2 times daily. The effect is gradual, visible after 4-8 weeks.

Does CBD support concentration?

Indirectly, through the reduction of tension and anxiety. CBD is not a stimulant like caffeine; it does not directly increase alertness. However, it acts antagonistically on stress "noise" that distracts attention. For dedicated concentration support, researchers increasingly point to CBG, which has a more "focusing" profile through the activation of the alpha-2 adrenergic receptor (PMC, Frontiers in Pharmacology, 2020).

Frontiers in Pharmacology published a review in 2020 of 132 studies on CBD, identifying confirmed efficacy in drug-resistant epilepsy (Epidiolex, FDA 2018) and strong clinical signals in anxiety, insomnia, chronic pain, and skin inflammation. For many indications, there is still a lack of randomized studies in large populations, but the safety profile remains favorable (Frontiers in Pharmacology, 2020).

Unique observation: In the Polish consumer segment, CBD is increasingly chosen as a complement to magnesium and adaptogens, rather than a standalone "cure-all". Customers combine CBD oil with magnesium chelate (e.g. Aura Care Magnesium B6 Chelate) and ashwagandha, treating cannabinoids as one element of their daily wellness routine. This is a healthy approach that reduces the risk of excessive expectations.

Interactions of CBD with medications

This is one of the most important areas of safety, often overlooked in marketing. CBD inhibits cytochrome P450 enzymes, mainly CYP3A4 and CYP2C9, which are responsible for the metabolism of about 60% of drugs on the pharmaceutical market (PMC, 2019). Ignoring this interaction can lead to unexpected effects of medications taken simultaneously.

With which medications does CBD have the strongest interactions?

The most clinically significant interactions of CBD involve: warfarin (increased bleeding risk due to enhanced anticoagulant effect), statins (e.g., atorvastatin, simvastatin, increased concentration and risk of myopathy), some SSRI antidepressants (increased serum concentration), benzodiazepines (increased sedation), antiepileptic drugs (clobazam, valproate), proton pump inhibitors. This list is not exhaustive, so consultation with a physician or clinical pharmacist is necessary (PMC, 2019).

Can CBD be combined with alcohol?

Not recommended. Both compounds have sedative effects; their combination enhances drowsiness, coordination disturbances, and the risk of lowering blood pressure. CBD does not neutralize the effects of alcohol, even though marketing messages sometimes suggest this. If you want to try, start with very small doses and do not drive. It is best to space them out: alcohol in the evening, CBD the next morning or vice versa.

How to space out CBD and medications?

Practical tip: take CBD at least 2 hours before or after a medication metabolized by CYP3A4. This does not eliminate the interaction but reduces its scale by spacing out the peaks of serum concentration. The safest strategy is to consult a clinical pharmacist who can tailor the regimen individually. Do not discontinue medications on your own initiative or increase doses without the knowledge of your attending physician.

A 2019 PMC review confirms that CBD is a strong inhibitor of CYP3A4 and CYP2C9, two key isoenzymes of cytochrome P450 responsible for the metabolism of about 60% of drugs on the market. This has clinical significance for patients taking warfarin, statins, antiepileptic drugs, and selected SSRI antidepressants (PMC, Medicines, 2019).

Purchasing CBD and product quality

The Polish CBD market offers hundreds of products in various price and quality ranges. Project CBD in 2023 indicates that about 40% of tested CBD oils on the American market had an actual cannabidiol content differing by more than 10% from the label declaration (Project CBD, 2023). Therefore, the ability to read COA and choose quality is crucial.

What is COA and how to read it?

COA (Certificate of Analysis) is a certificate from an independent laboratory, most often accredited to ISO 17025. It should include: declared and measured content of CBD, CBG, CBN, CBC, THC in mg/g or %, absence of heavy metals (Pb, Cd, As, Hg) below limits, absence of pesticides, absence of solvent residues from extraction, absence of mycotoxins and microbiology, test date, and batch number. Without a COA, it is unclear what you are actually buying.

How to recognize a good CBD oil?

A good CBD oil meets: a current COA from an accredited laboratory available online, declared CBD content in mg per bottle (not just percentage), information about the spectrum (broad/full/isolate), carrier (most often MCT oil, hemp oil, or olive oil), production date and batch number, dark glass bottle protecting against light, dropper with markings for precise dosing, transparent information about the source of the raw material and extraction method.

How much does good CBD oil cost?

Market price depends on concentration. A 5% oil (500 mg in 10 ml) typically costs 70-100 PLN, a 10% oil (1000 mg) about 90-180 PLN, and a 15-20% oil about 150-300 PLN. Very low prices (e.g., 40 PLN for 10% oil) should raise suspicions: the product likely has a lower actual CBD content or poorer extraction quality. Very high prices do not always mean proportionally better quality; the COA is key.

Where to buy CBD in Poland?

Safest in specialized hemp shops with published COAs for each batch. Pharmacies offer selected products but often with a markup higher than in online stores. Avoid products without certification, without declared concentrations in mg, or with unclear compositions. Trusted stores in Poland publish full technical documentation and respond to substantive questions.

Frequently Asked Questions (FAQ)

Is CBD legal in Poland in 2026?

Yes. CBD derived from hemp is legal if the THC content in the final product does not exceed 0.3%. This is regulated by the Act on Counteracting Drug Addiction Dz.U. 2005 No. 179 item 1485 with subsequent amendments. Cannabidiol is not listed as a controlled substance (ISAP, 2024).

What is a safe starting dose of CBD?

10-20 mg of CBD daily, divided into 1-2 doses, increased every 3-7 days until the effect is achieved. WHO assessed CBD as well tolerated in humans at doses up to 1500 mg daily (WHO, 2018). Project CBD recommends the "start low, go slow" protocol (Project CBD, 2023). The optimal zone usually falls within 25-75 mg daily.

Will CBD help me sleep?

With a high probability, yes. In a retrospective study from the Permanente Journal in 2019, 66.7% of patients reported improved sleep after a month of using CBD at doses of 25-75 mg daily (Permanente Journal, 2019). The full effect appears after 2-4 weeks. CBD is not a classic sleeping pill; it works indirectly by reducing tension.

Will CBD affect a drug test?

Standard tests detect THC, not CBD. Broad spectrum products without THC usually do not yield a positive result. Full-spectrum products with 0.3% THC may, however, result in THC detection in urine after prolonged use at high doses (Frontiers in Pharmacology, 2020). Professional drivers and athletes should choose only broad spectrum.

Does CBD cause a high or addiction?

No. The WHO Expert Committee on Drug Dependence confirmed in 2018 that CBD does not induce euphoria, is not addictive, and has no abuse potential (WHO, 2018). CBD's affinity for the CB1 receptor is millions of times weaker than that of THC, which is why it does not affect perception or consciousness. This is a key difference between the two cannabinoids.

Does CBD interact with medications?

Yes. CBD inhibits cytochrome P450 enzymes (CYP3A4 and CYP2C9), which metabolize about 60% of drugs on the market (PMC, 2019). Special caution is required for warfarin, statins, antiepileptic drugs, and some SSRI antidepressants. Before combining with pharmacotherapy, consult your physician or clinical pharmacist.

What is COA and do I always need it?

COA (Certificate of Analysis) is a certificate from an independent laboratory confirming the content of cannabinoids and the absence of contaminants. Yes, every good product should have a current COA. Project CBD indicates that about 40% of tested oils on the American market had CBD content differing by more than 10% from the label declaration (Project CBD, 2023).

What is better: CBD oil, capsules, or gummies?

Sublingual oil drops have the fastest absorption (15-45 minutes) and a bioavailability of 13-19%, plus dosing flexibility. Capsules work slower (60-120 minutes) with a bioavailability of 6-15%, but are more convenient for travel. Gummies are a flavored variant of capsules. Project CBD states that about 78% of global CBD consumers choose oils (Project CBD, 2023).

Summary: CBD in one sentence

CBD is a well-researched, non-psychoactive cannabinoid with a favorable safety profile that, by modulating the endocannabinoid system, can support sleep, reduce anxiety and tension, alleviate inflammatory pain, and aid recovery after training. It does not replace medications, does not cure by itself, but in many cases serves as a valuable complement to a conscious wellness routine.

The key principles are simple. Start with low doses of 10-20 mg daily and gradually increase. Choose broad spectrum products with a current COA. Give yourself 3-4 weeks to assess the full effect. Consult your doctor if you are taking medications metabolized by CYP3A4. Do not use during pregnancy or while breastfeeding. Remember that individual reactions can vary significantly from the population average.

The Polish CBD market is maturing, consumer awareness is growing, and the selection of products is expanding. The best results are achieved by those who treat CBD as part of a broader health strategy: good sleep, movement, diet, and stress reduction. Cannabinoids are not a magic pill, but a scientifically validated support tool, the effectiveness of which has been documented in hundreds of publications in PubMed, Frontiers in Pharmacology, and clinical journals. Let this FAQ serve as a map to return to in case of doubts.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis, CBD, or other cannabinoids for therapeutic purposes, consult your doctor, especially if you are taking other medications, are pregnant, breastfeeding, or have chronic liver conditions.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Next review: April 26, 2027